All Work

Chris Lange

How Akari Therapeutics Is Putting Itself on the Map

Shares of Akari Therapeutics saw a handy gain on Friday after the firm announced that the FDA granted a Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria.

Chris Lange · 10 years ago

How BlackBerry Won Big in Q4

BlackBerry reported mixed fiscal fourth-quarter financial results before the markets opened on Friday.

Chris Lange · 10 years ago

Many Analysts Ratings and Target Changes Seen in Oil & Gas

Thursday’s top analyst upgrades, downgrades and initiations contained many individual stock calls. Also seen was an unusual number of changes in analyst ratings, targets and estimates in the energy sector.

Chris Lange · 10 years ago

Lululemon Gets Downward Dog on Guidance

Lululemon Athletica Inc. (NASDAQ: LULU) reported its most recently quarterly earnings after the markets closed on Wednesday. The company posted $0.99 in earnings per share (EPS) and $789.9 million in revenue, versus consensus estimates…

Chris Lange · 10 years ago

Wednesday’s Biggest Winners and Losers in the S&P 500

March 29, 2017: The S&P 500 closed higher on the day, up 0.11 % and 2.56 points to 2,361.14. Separately the DJIA closed down 0.20% on the day at 20,659.39, down approximately 42.11 points.…

Chris Lange · 10 years ago

Tuesday’s Top Biopharma Movers

A few biopharma stocks made massive runs on Tuesday morning as the result of clinical trial results and earnings. Although not all of these moves were positive the overall sentiment was positive.

Chris Lange · 10 years ago

SEC Halts Chicago Firm’s Fraud Targeting Seniors

The SEC has announced an emergency asset freeze and temporary restraining order against a Chicago-based investment adviser accused of scamming elderly investors out of millions of dollars.

Chris Lange · 10 years ago